GLUCOSE PROCEDURE, TEKPOINT DIRECT— 510(k) K770455

Substantially Equivalent

Icn Pharmaceuticals, Inc.

FDA 510(k) clearance K770455 for GLUCOSE PROCEDURE, TEKPOINT DIRECT, Substantially Equivalent on 1977-05-03. Applicant: Icn Pharmaceuticals, Inc..

Clearance details

Applicant: Icn Pharmaceuticals, Inc.
Product code: Code CGE
Advisory panel: Clinical Chemistry
Date received: 1977-03-08
Decision date: 1977-05-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Orangeburg, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.